Detection of T-wave alternans using an implantable cardioverter-defibrillator

被引:33
|
作者
Paz, Offir
Zhou, Xiaohong
Gillberg, Jeff
Tseng, Hsiang-Jer
Gang, Eli
Swerdlow, Charles
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Medtronic Inc, Minneapolis, MN USA
关键词
tachyarrhythmias; T-wave alternans; implantable cardioverter-defibrillator;
D O I
10.1016/j.hrthm.2006.03.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Microvolt T-wave alternans (TWA) increases acutely prior to ventricular tachycardia (VT) or ventricular fibrillation (VF) in computer simulations and animal models, suggesting that TWA may provide a warning for VT/VF in patients with an implantable cardioverter-defibrillator (ICD). Objectives The purposes of this study were to develop a method for analyzing TWA recorded from ICD electrograms (EGMs) and to evaluate the degree of concordance between EGM TWA and TWA recorded from the surface ECG. Methods We developed a software program to measure EGM TWA in the frequency domain and then used simulated EGMs to determine the effects of ICD signal processing, electrical noise, and variation in the EGM fiducial point on the recorded amplitude and K score (signal-to-noise ratio) of TWA. We then applied this method to analyze TWA simultaneously using both surface ECGs and ICD EGMs during incremental pacing in 25 ICD patients. Pacing modes and EGM sources were varied in repeated trials. EGMs with dynamic range adjusted to achieve a Large T wave were telemetered to a digital Hotter recorder and measured offline. ECG TWA was analyzed using a commercial system. A positive (+) ECG test had sustained alternans >= 1.9 mu V with K score >= 3. Stored EGMs were reviewed for VT/VF during a 6-month follow-up period. Results Simulations demonstrated that the EGM method accurately identified TWA >= 10 mu V. Overall, 10 (40%) patients had at least one ECG TWA+ test and 15 patients (60%) had no ECG TWA+ tests. The maximum value of TWA was greater in EGMs than in ECGs (median 64 mu V vs 2.2 mu V, P<.0001). EGM TWA was greater in ECG TWA+ tests than in ECG TWA- tests (169 +/- 175 AV vs 71 +/- 61 mu V, P<.001). Using a sustained EGM TWA threshold of 30 mu V, EGM TWA was concordant with ECG TWA in 63 (84%) of 75 analyzed tests (P<.0001) and predicted ECG TWA results with 85% sensitivity and 84% specificity. Both ECG and EGM TWA predicted VT/VF during follow-up (ECG: P=.006; EGM: P=.035). Conclusion The amplitude of TWA is at Least 10 times greater on ICD EGMs than on surface ECGs. EGM and ECG TWA have substantial concordance and comparable predictive value for spontaneous VT/VF. These observations support the hypothesis that ECG and EGM TWA detect the same electrical alternans phenomenon.
引用
收藏
页码:791 / 797
页数:7
相关论文
共 50 条
  • [1] Implantable cardioverter-defibrillator shocks increase T-wave alternans
    Lampert, Rachel
    Shusterman, Vladimir
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (09) : E25 - E25
  • [2] Implantable cardioverter-defibrillator shocks increase T-Wave Alternans
    Lampert, Rachel J.
    Soufer, Robert
    McPherson, Craig A.
    Batsford, William P.
    Tirado, Stephanie
    Earley, Christine
    Goldberg, Anna
    Shusterman, Vladimir
    [J]. CIRCULATION, 2006, 114 (18) : 475 - 475
  • [3] Implantable cardioverter-defibrillator shocks increase T-wave alternans
    Lampert, Rachel
    Soufer, Robert
    McPherson, Craig A.
    Batsford, William P.
    Tirado, Stephanie
    Earley, Christine
    Goldberg, Anna
    Shusterman, Vladimir
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (05) : 512 - 517
  • [4] Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary Prevention
    Pelli, Ari
    Kentta, Tuomas V.
    Junttila, M. Juhani
    Huber, Cynthia
    Schlogl, Simon
    Zabel, Markus
    Malik, Marek
    Willems, Rik
    Vos, Marc A.
    Harden, Markus
    Friede, Tim
    Sticherling, Christian
    Huikuri, Heikki V.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (11):
  • [5] MICROVOLT T-WAVE ALTERNANS AS A PREDICTOR OF MORTALITY AND SEVERE ARRHYTHMIAS IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    Zhang, Cun-Tai
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E735 - E735
  • [6] Feasibility of T-wave alternans testing in patients considered for a cardioverter-defibrillator implantation
    Madias, J. E.
    [J]. NETHERLANDS HEART JOURNAL, 2012, 20 (05) : 247 - 247
  • [7] Feasibility of T-wave alternans testing in patients considered for a cardioverter-defibrillator implantation
    J. E. Madias
    [J]. Netherlands Heart Journal, 2012, 20 : 247 - 247
  • [8] Various patterns of intracardiac electrogram T-wave alternans prior to ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients
    Ikeda, Takanori
    Yusu, Satoru
    Yokoyama, Yasuhiro
    [J]. HEART RHYTHM, 2012, 9 (07) : 1033 - 1037
  • [9] Should T-wave alternans testing be used to risk stratify candidates for prophylactic implantable cardioverter-defibrillator therapy?
    Rashba, EJ
    [J]. HEART RHYTHM, 2005, 2 (03) : 242 - 244
  • [10] T-wave alternans, heart rate turbulence and ventricular extrasystoles for the prediction of appropriate implantable cardioverter-defibrillator discharges
    Seegers, J.
    Exposito, P. Munoz
    Hofschulte, F.
    Wessels, A.
    Lercher, H.
    Sohns, C.
    Luethje, L.
    Vollmann, D.
    Hasenfuss, G.
    Zabel, M.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 266 - 266